2022
Transfusion support for the oncology patient
Stendahl K, Schulz W, Snyder E. Transfusion support for the oncology patient. 2022, 482-488. DOI: 10.1002/9781119719809.ch41.ChaptersOncology patientsTransfusion supportBlood productsRed blood cell transfusionAntibiotic-refractory infectionsAppropriate blood productsChronic transfusion supportMost oncology patientsSignificant transfusion reactionsBlood cell transfusionGranulocyte infusionsCell transfusionSevere neutropeniaOxygen-carrying capacityAppropriate therapyTransfusion therapyTransfusion reactionsPatientsABO antigensABO groupHost antibodiesTransfusion servicesRBC unitsBlood componentsWhole blood
2019
Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
Bahar B, Schulz WL, Gokhale A, Spencer BR, Gehrie EA, Snyder EL. Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets. British Journal Of Haematology 2019, 188: 465-472. PMID: 31566724, PMCID: PMC7003815, DOI: 10.1111/bjh.16187.Peer-Reviewed Original ResearchConceptsPathogen-reduced plateletsTransfusion reactionsPlatelet componentsAdult patientsPlatelet transfusionsSeptic transfusion reactionsRed blood cell transfusion requirementsPR plateletsYale-New Haven HospitalPlatelet component transfusionsComparable clinical efficacyType of transfusionTransfusion requirementsTransfusion trendsPlatelet administrationComponent transfusionClinical efficacyNumber of RBCsConventional plateletsBlood utilisationPatientsTransfusionMean timePlateletsRBCsBlood Utilization and Transfusion Reactions in Pediatric Patients Transfused with Conventional or Pathogen Reduced Platelets
Schulz WL, McPadden J, Gehrie EA, Bahar B, Gokhale A, Ross R, Price N, Spencer BR, Snyder E. Blood Utilization and Transfusion Reactions in Pediatric Patients Transfused with Conventional or Pathogen Reduced Platelets. The Journal Of Pediatrics 2019, 209: 220-225. PMID: 30885645, DOI: 10.1016/j.jpeds.2019.01.046.Peer-Reviewed Original ResearchConceptsRed cell utilizationTransfusion reactionsNICU patientsInfants 0Platelet dosesNeonatal intensive care unit patientsPathogen-reduced platelet transfusionsIntensive care unit patientsTertiary care hospitalCare unit patientsShort-term safetyChildren ages 1Similar utilization patternsQuality assurance reviewPED patientsTransfusion trendsSubsequent transfusionsUnit patientsCare hospitalPediatric patientsPediatric populationPlatelet transfusionsBlood utilizationAdditional dosesPLT transfusions